Brief, Broad-Area Treatment Clears Actinic Keratosis
ORLANDO -- Patients with actinic keratosis (AK) had almost an 80% reduction in lesion count after three applications of an ingenol derivative formulated for broad-area treatment, according to a study reported here. After 8 weeks, the number of facial and chest lesions had decreased by 79% and the number of scalp lesions by 76% in response to treatment with ingenol disoxate. About 40% of patients had complete clearance of lesions at 8 weeks.
Read the rest of the article at medpagetoday.com